Azapropazone is a nonsteroidal anti-inflammatory drug (NSAID). It is manufactured by Goldshield under the tradename Rheumox.[1]
Clinical data | |
---|---|
Trade names | Rheumox |
AHFS/Drugs.com | International Drug Names |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 20 hours |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.033.543 |
Chemical and physical data | |
Formula | C16H20N4O2 |
Molar mass | 300.362 g·mol−1 |
3D model (JSmol) |
|
Chirality | Racemic mixture |
| |
| |
(what is this?) (verify) |
It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects.[2] Azopropazone has now been discontinued in the British National Formulary.
Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.[3]